- Home
- CLLS vs FBYD Comparison
CLLS vs FBYD Comparison
Compare CLLS & FBYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLLS | FBYD |
|---|---|---|
| Founded | 1999 | 2021 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.4M | 360.1M |
| IPO Year | 2014 | 2023 |
Fundamental Metrics
Financial Performance| Metric | CLLS | FBYD |
|---|---|---|
| Price | $1.43 | $8.52 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $5.33 | N/A |
| AVG Volume (30 Days) | ★ 171.9K | 113.4K |
| Earning Date | 11-06-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $14,896,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.70 | N/A |
| P/E Ratio | ★ N/A | $211.25 |
| Revenue Growth | N/A | ★ 120.85 |
| 52 Week Low | $1.25 | $3.71 |
| 52 Week High | $5.48 | $29.02 |
Technical Indicators
Market Signals| Indicator | CLLS | FBYD |
|---|---|---|
| Relative Strength Index (RSI) | 26.03 | 54.10 |
| Support Level | $1.31 | $6.01 |
| Resistance Level | $3.47 | $8.65 |
| Average True Range (ATR) | 0.14 | 0.63 |
| MACD | -0.01 | 0.33 |
| Stochastic Oscillator | 17.81 | 92.77 |
Price Performance
Historical ComparisonAbout CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About FBYD Falcon's Beyond Global Inc.
Falcons Beyond Global Inc is a visionary entertainment and technology enterprise. The group designs, develops, engineers, delivers, and commercializes immersive physical and digital experiences for brands, developers, and destination operators world-wide, as well as for its own portfolio of entertainment and technology concepts. The Company has five operating segments: Falcon's Creative Group, Destinations Operations, PDP, Falcon's Beyond Brands, and Falcon's Attractions. It earns the majority of the revenue from Falcon's Creative Group segment.